All In MedTech

FDA Clearance Tracker · P070001-S025

prodisc C SK and prodisc C Vivo

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 10, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 10, 2025

Approved

Time to decision

744 days

Received Sep 27, 2023. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Panel Track

Device class

Class III

The decision

FDA number
P070001-S025
Device name
prodisc C SK and prodisc C Vivo
Applicant location
West Chester, PA
Received
Sep 27, 2023
Decided
Oct 10, 2025
Decision
Approved
Supplement type
Panel Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P070001

Device type

Device class
Class III

Every decision under product code MJO

FDA's approval statement

As written in FDA's record.

The prodisc® C SK and prodisc® C Vivo are both indicated for use in skeletally mature patients for reconstruction of the disc from C3-C7 following discectomy at one or two contiguous levels for intractable radiculopathy (arm pain and/or a neurological deficit) with or without neck pain, or myelopathy due to abnormality localized to the level of the disc space and at least one of the following conditions confirmed by radiographic imaging (CT, MRI, X-rays): herniated nucleus pulposus, spondylosis (defined by the presence of osteophytes), and/or visible loss of disc height as compared to adjacent levels. The prodisc® C SK and prodisc® C Vivo are implanted using an anterior approach. Patients should have failed at least 6 weeks of conservative treatment or demonstrated progressive signs or symptoms despite non-operative treatment prior to implantation of the prodisc® C SK and prodisc® C Vivo.

Source documents

Other decisions for Centinel Spine, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

2 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.